查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1733193

全球青光眼手术器械市场规模（按产品类型、手术类型、最终用户、区域范围和预测）

Global Glaucoma Surgery Devices Market Size By Product, By Surgery Type, By End-Users, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

青光眼手术设备市场规模及预测

2024 年青光眼手术设备市场规模为 11.3386 亿美元，预计到 2032 年将达到 70.0606 亿美元，2026 年至 2032 年的复合年增长率为 28.20%。

  • 青光眼手术设备是用于青光眼手术治疗的专用设备，青光眼是全球不可逆失明的主要原因。
  • 这些设备用于各种手术，包括小梁切除术、管分流手术和微创青光眼手术 (MIGS)。
  • 这些设备的应用对于降低眼压 (IOP) 和保护青光眼患者的视力至关重要。
  • 人口老化和青光眼盛行率的上升推动了对青光眼治疗创新有效解决方案的需求。
  • 这一趋势导致了技术和手术技术的重大进步，提高了青光眼手术的有效性和安全性。
  • 因此，我们预计，在持续研发的支持下，这些设备在已开发市场和新兴市场的采用率都将显着增加。

全球青光眼手术器材市场动态

影响全球青光眼手术设备市场的关键市场动态是：

关键市场驱动因素

  • 青光眼的盛行率：青光眼在世界各地的盛行率很高，据报导有数百万人受到这种慢性疾病的影响。预计患者数量的增加将大大增加对青光眼手术设备的需求。根据系统性系统综述和统合分析，预计 2020 年全球青光眼患者人数为 7,600 万人，到 2040 年将增加到 1.118 亿人。
  • 人口老化：老化社会导致与老龄化相关的眼科疾病（包括青光眼）的发生率增加。预计老年人口的增加将增加对有效外科手术介入的需求。
  • 技术进步：青光眼手术设备领域正在见证越来越多的技术进步，从而提高安全性和有效性。这些技术创新有望透过为患者提供更好的治疗选择来刺激市场成长。
  • 医疗保健支出：医疗保健支出增加，尤其是在已开发地区，这可能会推动对先进医疗设备的投资。随着医院和诊所寻求提高其手术能力，这一趋势预计将推动青光眼手术设备的采用。

主要问题

  • 设备成本高：青光眼手术设备的高成本被认为是主要限制因素。如此高的成本预计将限制一些医疗保健提供者获得医疗服务的机会，尤其是在新兴市场。
  • 报销问题：许多医疗保健系统面临报销问题，并且对青光眼手术的报销范围不一致。这些挑战预计将阻碍青光眼手术设备市场的成长，因为医院可能会犹豫是否在没有报销确定性的情况下投资先进技术。
  • 缺乏熟练的专家：缺乏接受过先进青光眼手术技术训练的熟练专家。预计这种短缺将阻碍创新青光眼手术设备在临床实践中的有效采用和利用。
  • 患者意识：患者对青光眼及其治疗方法的认识通常有限，尤其是在开发中地区。据估计，缺乏这种认知会阻碍对青光眼手术设备的需求，因为患者可能不会及时寻求治疗。

主要趋势

  • 对微创手术的需求：患者和医疗保健提供者对微创手术的需求都很高。预计这一趋势将导致专为微创手术设计的青光眼手术设备的采用率增加，有助于缩短恢復时间。
  • 数位科技的整合：据报道，青光眼管理领域人工智慧和远端医疗等数位技术的整合日益加强。这些进步有望提高诊断准确性和手术计划，推动相关手术设备市场的发展。
  • 注重个人化医疗：青光眼治疗越来越注重个人化医疗。预计这一趋势将推动定製手术干预和设备的发展，以满足个别患者的需求。
  • 製造商和医疗保健提供者之间的合作：我们看到青光眼手术设备製造商和医疗保健提供者之间的合作日益增多。这将促进知识和资源的共用，并有望促进创新产品的开发和手术效果的改善。

目录

第一章全球青光眼手术器械市场介绍

  • 市场介绍
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章 青光眼手术器械全球市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章全球青光眼手术器械市场（按产品）

  • 概述
  • 青光眼引流装置
  • 青光眼雷射设备
  • 植入和支架

6. 全球青光眼手术器械市场（依手术类型）

  • 概述
  • 微创青光眼手术
  • 传统青光眼手术

7. 全球青光眼手术器械市场（依最终用户）

  • 概述
  • 眼科医院和眼科诊所
  • 门诊手术中心
  • 门诊手术中心

8. 全球青光眼手术器材市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 其他的
    • 拉丁美洲
    • 中东和非洲

第九章全球青光眼手术设备市场的竞争格局

  • 概述
  • 各公司市场排名
  • 重点发展策略

第十章 公司简介

  • Carl Zeiss Meditec AG
  • Abbott Laboratories
  • Iridex Corporation
  • Alcon, Inc.
  • Glaukos Corporation
  • ASICO
  • Katalyst Surgical
  • Ziemer Ophthalmic Systems AG
  • Lumenis Ltd.

第十一章 附录

  • 相关调查
简介目录
Product Code: 33171

Glaucoma Surgery Devices Market Size And Forecast

Glaucoma Surgery Devices Market size was valued at USD 1133.86 Million in 2024 and is projected to reach USD 7006.06 Million by 2032, growing at a CAGR of 28.20% from 2026 to 2032.

  • Glaucoma surgery devices are specialized instruments used in the surgical management of glaucoma, a leading cause of irreversible blindness worldwide.
  • These devices are utilized in various procedures, including trabeculectomy, tube shunt surgery, and minimally invasive glaucoma surgery (MIGS).
  • The application of these devices is essential in lowering intraocular pressure (IOP) and preserving vision in patients diagnosed with glaucoma.
  • A growing demand for innovative and effective solutions in glaucoma treatment is being witnessed, driven by an aging population and a rising prevalence of the disease.
  • This trend has led to significant advancements in technology and surgical techniques, enhancing the effectiveness and safety of glaucoma surgeries.
  • Consequently, a notable increase in the adoption of these devices is anticipated in both developed and emerging markets, supported by ongoing research and development efforts.

Global Glaucoma Surgery Devices Market Dynamics

The key market dynamics that are shaping the global glaucoma surgery devices market include:

Key Market Drivers:

  • Prevalence of Glaucoma: A high prevalence of glaucoma is being reported globally, with millions of individuals affected by this chronic condition. It is anticipated that this growing patient population will drive the demand for glaucoma surgery devices significantly. According to a systematic review and meta-analysis, the number of people with glaucoma worldwide was estimated to be 76 million in 2020, with projections suggesting this number will increase to 111.8 million by 2040.
  • Aging Population: A growing aging population is being observed, leading to an increased incidence of age-related eye diseases, including glaucoma. The rising number of elderly individuals is expected to contribute to the demand for effective surgical interventions.
  • Advancements In Technology: Increasing advancements in technology are being made in the field of glaucoma surgery devices, enhancing their safety and efficacy. These innovations are projected to stimulate market growth by providing better treatment options for patients.
  • Healthcare Expenditure: A rising healthcare expenditure is being noted, particularly in developed regions, which is likely to facilitate investment in advanced medical devices. This trend is expected to support the adoption of glaucoma surgery devices as hospitals and clinics seek to upgrade their surgical capabilities.

Key Challenges:

  • High Costs of Devices: The high costs associated with glaucoma surgery devices are being identified as a significant restraint. It is anticipated that these elevated expenses will limit access for some healthcare providers, especially in emerging markets.
  • Reimbursement Issues: Reimbursement issues are being faced by many healthcare systems, where coverage for glaucoma surgeries is not consistently provided. It is expected that these challenges will impede the growth of the glaucoma surgery devices market as hospitals may hesitate to invest in advanced technologies without assured reimbursement.
  • Lack of Skilled Professionals: A lack of skilled professionals trained in advanced glaucoma surgical techniques is being noted. This shortage is projected to restrain the effective implementation and utilization of innovative glaucoma surgery devices in clinical settings.
  • Patient Awareness: Patient awareness regarding glaucoma and its surgical treatment options is often limited, particularly in developing regions. It is estimated that this lack of awareness will hamper the demand for glaucoma surgery devices, as individuals may not seek timely treatment.

Key Trends:

  • Demand for Minimally Invasive Procedures: A high demand for minimally invasive procedures is being observed among both patients and healthcare providers. It is anticipated that this trend will lead to the increased adoption of glaucoma surgery devices specifically designed for less invasive techniques, promoting quicker recovery times.
  • Integration of Digital Technologies: Growing integration of digital technologies, such as artificial intelligence and telemedicine, is being reported in the glaucoma management sector. These advancements are expected to enhance the diagnostic accuracy and surgical planning, thereby driving the market for associated surgical devices.
  • Focus on Personalized Medicine: An increasing focus on personalized medicine is being recognized within the glaucoma treatment landscape. It is projected that this trend will encourage the development of tailored surgical interventions and devices that cater to individual patient needs.
  • Collaboration Between Manufacturers and Healthcare Providers: Rising collaboration between manufacturers of glaucoma surgery devices and healthcare providers is being noted. It is likely to facilitate the sharing of knowledge and resources, resulting in the development of innovative products and improved surgical outcomes.

Global Glaucoma Surgery Devices Market Regional Analysis

Here is a more detailed regional analysis of the global glaucoma surgery devices market:

North America:

  • North America is expected to dominate the glaucoma surgery devices market due to advanced healthcare infrastructure and high prevalence rates of glaucoma.
  • According to the National Eye Institute, more than 3 million Americans had glaucoma in 2020, a number projected to reach 4.2 million by 2030.
  • The United States is anticipated to hold the largest share, driven by the presence of key market players and a strong emphasis on research and development.
  • Increasing healthcare expenditures and a growing elderly population are projected to further contribute to market growth in the region.
  • In Canada, a rising awareness of eye health is being observed, leading to more frequent screenings and diagnoses of glaucoma.
  • It is estimated that advancements in minimally invasive surgical techniques will enhance the adoption of glaucoma surgery devices.
  • The presence of a robust healthcare system is likely to support the ongoing growth of this market segment.

Europe:

  • Europe is anticipated to experience significant growth in the glaucoma surgery devices market, attributed to the increasing aging population and high incidence of glaucoma across the region.
  • According to Eurostat, the percentage of people aged 65 and over in the EU-27 is projected to increase from 20.3% in 2019 to 29.4% by 2050. The European Glaucoma Society reports that the prevalence of glaucoma in Europe is approximately 2.93% in people over 40, rising to 5.1% in those over 75.
  • Countries such as Germany and France are projected to lead the market, driven by a combination of advanced healthcare facilities and government initiatives aimed at improving eye care services.
  • Rising investments in innovative surgical technologies are expected to foster market expansion in these nations.
  • The United Kingdom is also likely to contribute to regional growth through the implementation of public health campaigns focusing on glaucoma awareness.
  • Enhanced access to advanced surgical procedures is projected to boost the adoption of glaucoma surgery devices.
  • Additionally, collaborations between healthcare providers and device manufacturers are anticipated to facilitate the development of new and effective treatment options.

Global Glaucoma Surgery Devices Market: Segmentation Analysis

The Global Glaucoma Surgery Devices Market is Segmented on the basis of Product, Surgery Type, End-Users, And Geography.

Glaucoma Surgery Devices Market, By Product

  • Glaucoma Drainage Devices
  • Glaucoma Laser Devices
  • Implants And Stents

Based on Product, the market is bifurcated into Glaucoma Drainage Devices, Glaucoma Laser Devices, and Implants And Stents. Glaucoma drainage devices are expected to hold the largest share of the glaucoma surgery devices market due to their effectiveness in managing intraocular pressure (IOP) in patients with refractory glaucoma. Increasing prevalence rates of glaucoma and the growing elderly population are anticipated to drive demand for these devices significantly. The success of drainage devices in reducing IOP, especially in patients who have not responded well to conventional treatments, is projected to enhance their adoption in clinical settings.

Glaucoma Surgery Devices Market, By Surgery Type

  • Conventional Glaucoma Surgeries
  • Minimally Invasive Glaucoma Surgeries

Based on Surgery Type, the global Glaucoma Surgery Devices Market is divided into Conventional Glaucoma Surgeries and Minimally Invasive Glaucoma Surgeries. The segment of conventional glaucoma surgeries is expected to hold the largest share of the glaucoma surgery devices market. This segment includes established procedures such as trabeculectomy and tube shunt surgeries, which have been widely utilized for many years. A high prevalence of advanced glaucoma cases requiring surgical intervention is anticipated to drive demand in this category. The effectiveness of these traditional surgical methods in significantly lowering intraocular pressure is projected to enhance their continued use in clinical practice.

Glaucoma Surgery Devices Market, By End-Users

  • Eye Hospitals And Ophthalmology Clinics
  • Ambulatory Surgical Centers
  • Outpatient Surgical Centers

Based on End-Users, the market is segmented into Eye Hospitals And Ophthalmology Clinics, Ambulatory Surgical Centers, and Outpatient Surgical Centers. Eye hospitals and ophthalmology clinics are expected to hold the largest share of the glaucoma surgery devices market due to the increasing demand for specialized eye care services. These facilities are anticipated to benefit from a growing prevalence of glaucoma and a rising awareness among the population regarding eye health. The availability of advanced surgical technologies within these settings is likely to enhance treatment outcomes, thereby attracting more patients seeking glaucoma management.

Glaucoma Surgery Devices Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
  • On the basis of Geography, the global glaucoma surgery devices market is classified into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific region is expected to be a rapidly growing market for glaucoma surgery devices, primarily due to the rising prevalence of glaucoma among aging populations. Countries such as China and India are projected to witness significant increases in demand, driven by a combination of population growth and urbanization. Investments in healthcare infrastructure are likely to support the market's expansion in these countries.

Key Players

The "Global Glaucoma Surgery Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Carl Zeiss Meditec AG, Abbott Laboratories, Iridex Corporation, Alcon, Inc., Glaukos Corporation, ASICO, Katalyst Surgical, Nidek Co., Ltd., Ziemer Ophthalmic Systems AG, and Lumenis Ltd. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Glaucoma Surgery Devices Market Recent Developments
  • In July 2022, a strategic partnership for the treatment of glaucoma was announced by iSTAR Medical and AbbVie. This collaboration afforded AbbVie the opportunity to significantly diversify its line of eye care products and offer glaucoma patients more treatment options.
  • In November 2021, SMART Solutions by Alcon, a digital platform specifically created for ophthalmology, was demonstrated at the American Academy of Ophthalmology (AAO) 2021 annual conference by Alcon, the world leader in eye care committed to supporting people in seeing brilliantly. This innovative platform is reinforced by Alcon's leadership in the clinic-to-operating room, integration with image-guided technologies, and cloud-based planning

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL GLAUCOMA SURGERY DEVICES MARKET

  • 1.1 Introduction of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL GLAUCOMA SURGERY DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Glaucoma Drainage Devices
  • 5.3 Glaucoma Laser Devices
  • 5.4 Implants & Stents

6 GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE

  • 6.1 Overview
  • 6.2 Minimally Invasive Glaucoma Surgeries
  • 6.3 Conventional Glaucoma Surgeries

7 GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY END-USERS

  • 7.1 Overview
  • 7.2 Eye Hospitals & Ophthalmology Clinics
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Outpatient Surgical Centers

8 GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East & Africa

9 GLOBAL GLAUCOMA SURGERY DEVICES MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Carl Zeiss Meditec AG
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Abbott Laboratories
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Iridex Corporation
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Alcon, Inc.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Glaukos Corporation
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 ASICO
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Katalyst Surgical
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Ziemer Ophthalmic Systems AG
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Lumenis Ltd.
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments

11 Appendix

  • 11.1 Related Research"